Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Nov 2 | REGN | Regeneron Pharmaceuticals,… | FTAX | 4,243 | $950.50 | $4M | -16.3% | Open the original filing on SEC.gov |
| Nov 2 | REGN | Regeneron Pharmaceuticals,… | MEXER | 6,000 | $381.92 | $2.3M | +30.0% | Open the original filing on SEC.gov |
| Aug 18 | REGN | Regeneron Pharmaceuticals,… | MEXER◆ | 6,283 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | REGN | Regeneron Pharmaceuticals,… | FTAX | 4,599 | $813.47 | $3.7M | -18.7% | Open the original filing on SEC.gov |
| Aug 18 | REGN | Regeneron Pharmaceuticals,… | MEXER | 6,283 | $381.92 | $2.4M | +34.3% | Open the original filing on SEC.gov |
| Dec 8, 2025 | REGN | Regeneron Pharmaceuticals,… | FTAX | 992 | $712.94 | $707.2K | -5.1% | Open the original filing on SEC.gov |
| Dec 5, 2025 | REGN | Regeneron Pharmaceuticals,… | AGRANT◆ | 14,924 | — | — | — | Open the original filing on SEC.gov |
| Dec 5, 2025 | REGN | Regeneron Pharmaceuticals,… | AGRANT | 3,027 | — | — | +18.6% | Open the original filing on SEC.gov |